Počet záznamů: 1  

Xeno-Hybrid Bone Graft Releasing Biomimetic Proteins Promotes Osteogenic Differentiation of hMSCs

  1. 1.
    SYSNO ASEP0553281
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevXeno-Hybrid Bone Graft Releasing Biomimetic Proteins Promotes Osteogenic Differentiation of hMSCs
    Tvůrce(i) Zhu, H. (CN)
    Hefka Blahnová, Veronika (UEM-P)
    Perale, G. (AT)
    Xiao, J. (CN)
    Betge, F. (CZ)
    Boniolo, F. (DE)
    Filová, Eva (UEM-P) RID, ORCID
    Lyngstadaas, S. P. (NO)
    Haugen, A. (NO)
    Číslo článku619111
    Zdroj.dok.Frontiers in Cell and Developmental Biology. - : Frontiers Research Foundation - ISSN 2296-634X
    Roč. 8, dec. (2020)
    Poč.str.13 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovabone scaffold ; bone graft ; bone regeneration biomimetic ; bioactive proteins ; intrinsically disordered ; mesenchymal stem cells ; xenograft
    Obor OECDBiomaterials (as related to medical implants, devices, sensors)
    Způsob publikováníOpen access
    Institucionální podporaUEM-P - RVO:68378041
    UT WOS000604734100001
    EID SCOPUS85099013632
    DOI10.3389/fcell.2020.619111
    AnotaceBone defect is a noteworthy health problem and is the second most transplanted tissue after blood. Numerous bone grafts are designed and applied in clinics. Limitations, however, from different aspects still exist, including limited supply, mechanical strength, and bioactivity. In this study, two biomimetic peptides (P2 and P6) are incorporated into a composite bioactive xeno hybrid bone graft named SmartBonePep(R), with the aim to increase the bioactivity of the bone graft. The results, which include cytotoxicity, proliferation rate, confocal microscopy, gene expression, and protein qualification, successfully prove that the SmartBonePep(R) has multi-modal biological effects on human mesenchymal stem cells from bone marrow. The effective physical entrapment of P6 into a composite xeno-hybrid bone graft, withstanding manufacturing processes including exposure to strong organic solvents and ethylene oxide sterilization, increases the osteogenic potential of the stem cells as well as cell attachment and proliferation. P2 and P6 both show a strong biological potential and may be future candidates for enhancing the clinical performance of bone grafts.
    PracovištěÚstav experimentální medicíny
    KontaktLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Rok sběru2022
    Elektronická adresahttps://www.frontiersin.org/articles/10.3389/fcell.2020.619111/full
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.